103 related articles for article (PubMed ID: 38622715)
21. MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome.
Lucarelli G; Rutigliano M; Loizzo D; di Meo NA; Lasorsa F; Mastropasqua M; Maiorano E; Bizzoca C; Vincenti L; Battaglia M; Ditonno P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430448
[TBL] [Abstract][Full Text] [Related]
22. The cross-talk between Abl2 tyrosine kinase and TGFβ1 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells.
De Marco S; Torsello B; Minutiello E; Morabito I; Grasselli C; Bombelli S; Zucchini N; Lucarelli G; Strada G; Perego RA; Bianchi C
FEBS Lett; 2023 Apr; 597(8):1098-1113. PubMed ID: 36310399
[TBL] [Abstract][Full Text] [Related]
23. Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers.
Su C; Lv Y; Lu W; Yu Z; Ye Y; Guo B; Liu D; Yan H; Li T; Zhang Q; Cheng J; Mo Z
Front Oncol; 2021; 11():719564. PubMed ID: 34722263
[TBL] [Abstract][Full Text] [Related]
24. PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.
Feng C; Li Y; Li K; Lyu Y; Zhu W; Jiang H; Wen H
J Exp Clin Cancer Res; 2021 Sep; 40(1):308. PubMed ID: 34593007
[TBL] [Abstract][Full Text] [Related]
25. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
Ma W; Zhong M; Liu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
[TBL] [Abstract][Full Text] [Related]
26. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
27. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Liao Y; He D; Wen F
Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
[TBL] [Abstract][Full Text] [Related]
28. Metabolic reprogramming in renal cancer: Events of a metabolic disease.
Chakraborty S; Balan M; Sabarwal A; Choueiri TK; Pal S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188559. PubMed ID: 33965513
[TBL] [Abstract][Full Text] [Related]
29. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.
Bi K; He MX; Bakouny Z; Kanodia A; Napolitano S; Wu J; Grimaldi G; Braun DA; Cuoco MS; Mayorga A; DelloStritto L; Bouchard G; Steinharter J; Tewari AK; Vokes NI; Shannon E; Sun M; Park J; Chang SL; McGregor BA; Haq R; Denize T; Signoretti S; Guerriero JL; Vigneau S; Rozenblatt-Rosen O; Rotem A; Regev A; Choueiri TK; Van Allen EM
Cancer Cell; 2021 May; 39(5):649-661.e5. PubMed ID: 33711272
[TBL] [Abstract][Full Text] [Related]
30. Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Zhang Y; Chen M; Liu M; Xu Y; Wu G
Oxid Med Cell Longev; 2021; 2021():6699808. PubMed ID: 33564363
[TBL] [Abstract][Full Text] [Related]
31. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma.
Braun DA; Bakouny Z; Hirsch L; Flippot R; Van Allen EM; Wu CJ; Choueiri TK
Nat Rev Clin Oncol; 2021 Apr; 18(4):199-214. PubMed ID: 33437048
[TBL] [Abstract][Full Text] [Related]
32. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
Xiao Y; Jin L; Deng C; Guan Y; Kalogera E; Ray U; Thirusangu P; Staub J; Sarkar Bhattacharya S; Xu H; Fang X; Shridhar V
Oncogene; 2021 Feb; 40(8):1409-1424. PubMed ID: 33420377
[TBL] [Abstract][Full Text] [Related]
34. Identification of Novel Glycolysis-Related Gene Signatures Associated With Prognosis of Patients With Clear Cell Renal Cell Carcinoma Based on TCGA.
Wu C; Cai X; Yan J; Deng A; Cao Y; Zhu X
Front Genet; 2020; 11():589663. PubMed ID: 33391344
[TBL] [Abstract][Full Text] [Related]
35. Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Morozumi K; Sato M; Shimada S; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
Metabolites; 2020 Dec; 11(1):. PubMed ID: 33374949
[TBL] [Abstract][Full Text] [Related]
36. Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell Carcinoma.
Lucarelli G; Ferro M; Loizzo D; Bianchi C; Terracciano D; Cantiello F; Bell LN; Battaglia S; Porta C; Gernone A; Perego RA; Maiorano E; Cobelli O; Castellano G; Vincenti L; Ditonno P; Battaglia M
Metabolites; 2020 Dec; 10(12):. PubMed ID: 33322148
[TBL] [Abstract][Full Text] [Related]
37. The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma.
Xu F; Guan Y; Xue L; Huang S; Gao K; Yang Z; Chong T
BMC Cancer; 2020 Dec; 20(1):1207. PubMed ID: 33287763
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer.
Ghini V; Laera L; Fantechi B; Monte FD; Benelli M; McCartney A; Leonardo T; Luchinat C; Pozzessere D
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33265926
[TBL] [Abstract][Full Text] [Related]
39. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets.
Szklarczyk D; Gable AL; Nastou KC; Lyon D; Kirsch R; Pyysalo S; Doncheva NT; Legeay M; Fang T; Bork P; Jensen LJ; von Mering C
Nucleic Acids Res; 2021 Jan; 49(D1):D605-D612. PubMed ID: 33237311
[TBL] [Abstract][Full Text] [Related]
40. 36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells.
Bombelli S; Torsello B; De Marco S; Lucarelli G; Cifola I; Grasselli C; Strada G; Bovo G; Perego RA; Bianchi C
Am J Pathol; 2020 Nov; 190(11):2317-2326. PubMed ID: 32861643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
